GlassScriptPhysician profile
Mei-Lin Lu
NPI 1114907896
$824.44
in general payments reported to CMS, 2019-2025
14 companies · $93.02 in 2025
The $93.02 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $94.59 · 2021: $49.97 · 2022: $45.92 · 2023: $51.83 · 2024: $175 · 2025: $93.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $336.10 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $93.70 | 2020-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Cranial Technologies, INC | $82.34 | 2019-2024 | Doc Band |
| Seqirus USA INC | $50.46 | 2023-2024 | Flucelvax Quadrivalent, Flucelvax |
| Acadia Pharmaceuticals INC | $47.74 | 2024-2025 | Daybue |
| Ironshore Pharmaceuticals INC. | $44.16 | 2019 | |
| Sanofi-Aventis U.S. LLC | $30.92 | 2024 | |
| Sanofi US Services INC. | $26.50 | 2024 | |
| Adlon Therapeutics L.P. | $25.20 | 2020 | |
| Alk-Abello, INC | $21.93 | 2024 | Grastek, Odactra, Ragwitek |
| Sanofi Pasteur INC. | $17.46 | 2023 | |
| Glaxosmithkline, LLC. | $16.96 | 2025 | Bexsero |
| Cumberland Pharmaceuticals, INC. | $16.72 | 2020 | |
| Phadia US INC. | $14.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mei-Lin Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.